Please provide your email address to receive an email when new articles are posted on . Sulfonylureas were linked to risk for heart events vs. DPP-IVs for patients with type 2 diabetes at moderate CV ...

Highest risk seen with glipizide versus other sulfonylureas and DPP4 inhibitors as second-line therapy. (HealthDay News) — For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk ...

Among all study drugs, the highest rate was seen with glyburide. Compared to other oral antidiabetic monotherapies, sulfonylureas were associated with the highest rates of serious hypoglycemia, ...

Moderate-risk patients with diabetes treated with a sulfonylurea appear to be at a higher risk of major adverse cardiovascular events than those who receive a dipeptidyl peptidase-4 (DPP-4) inhibitor, ...

Adults with type 2 diabetes prescribed glyburide may have lower risks for sudden cardiac arrest and ventricular arrhythmia compared with those prescribed glipizide and glimepiride, according to ...

June 29, 2012 (Houston, Texas) — The diabetes drugs glipizide, glyburide, and glimepiride each show a significantly higher risk for mortality compared with metformin, according to an analysis of more ...

New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to a higher rate of heart-related conditions compared to medications that hit ...

Dr. Irl Hirsch answers the question: 'What Things/Actions Cause Hypoglycemia?' — -- Question: What's most likely to cause hypoglycemia? Answer: Well, certainly right up there are medications. In ...

Compared to another popular drug, three widely used diabetes medications are associated with a greater risk of death, a large new analysis finds. Compared to another popular drug, three widely used ...

An estimated 26 million Americans suffer from type-2 diabetes, with about 1 million new cases diagnosed each year. This serious disease can lead to numerous adverse health effects, including ...

Glipizide is an oral drug used to treat type 2 diabetes. It belongs to the sulfonylurea drug class, which also includes glimepiride Amaryl, glyburide Diabeta, Glynase, tolbutamide, and tolazamide. In ...

HealthDay News — For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk treated with metformin, the risk for major adverse cardiovascular events is highest for glipizide as a ...